Low dialysate sodium in children and young adults on maintenance hemodialysis: a prospective, randomized, crossover study

Pediatr Nephrol. 2023 May;38(5):1599-1607. doi: 10.1007/s00467-022-05792-y. Epub 2022 Oct 31.

Abstract

Background: The optimal dialysate sodium concentration (dNa) in children on hemodialysis (HD) is unknown. The aim of this study was to compare the effect on interdialytic weight gain (IDWG) and blood pressure (BP) of a low (135 mmol/l) and standard dNa (138 mmol/l) in children and young adults on maintenance HD.

Methods: This prospective single-blind randomized crossover study consisted of a randomized sequence of two phases: "standard dNa" of 138 mmol/L and "low dNa" of 135 mmol/L. Each phase lasted 4 weeks. Inclusion criteria were age < 25 years, hypertension, pre-HD serum Na (sNa) ≥ 130 mmol/L, and occurrence of symptoms in less than 25% of sessions. Primary outcomes were pre-HD systolic and diastolic BP and IDWG.

Results: Fifteen patients were recruited, mean age 17.8 ± 4.4 years. Pre-HD SBP and DBP were not different between the two treatments. Mean IDWG was significantly lower with low dNa than with standard dNa: 2.12 ± 1.39% vs. 2.77 ± 1.53%, respectively (p = 0.008). The first-hour refill index (a volume index based on blood-volume monitoring) was significantly lower with dNa 135 mmol/L (p = 0.018). The mean Na gradient (dNa-sNa) was - 2.53 ± 2.4 mmol/L with dNa 135 mmol/L and 0.17 ± 2.8 mmol/L with dNa 138 mmol/L (p = 0.0001). The incidence of symptomatic sessions was similar (1.0% vs. 1.0%).

Conclusions: In a selected population of hypertensive pediatric and young adult HD patients, a dNa of 135 mmol/L was associated with a significant reduction of IDWG compared with a dNa of 138 mmol/L. Furthermore, long-term studies are needed to investigate the effect of lowering dNa on BP. A higher resolution version of the Graphical abstract is available as Supplementary information.

Keywords: Children; Dialysis fluid sodium; Hemodialysis; Interdialytic weight gain; Sodium load.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Blood Pressure
  • Child
  • Cross-Over Studies
  • DNA
  • Dialysis Solutions / pharmacology
  • Humans
  • Hypertension* / complications
  • Hypertension* / etiology
  • Kidney Failure, Chronic* / complications
  • Prospective Studies
  • Renal Dialysis / adverse effects
  • Single-Blind Method
  • Sodium
  • Weight Gain
  • Young Adult

Substances

  • Dialysis Solutions
  • Sodium
  • DNA